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ABSTRACT 
D侵partm酎.t01 Pharmacology， Tottori University School 
。'1Medicine， Yonago， !atan 
The effects of zopiclone， chemicalIy unrelated to benzodiazepines， on the central nervous 
system were analyzed in mice， rats and rabbits. Moreover， the tolerance.producing Iiability 
and combined effects of zopiclone with other central acting drugs were tested. 
Zopiclone showed slight inhibitory e宜ectson spontaneous motor activities， maximal electro-
shock convulsion， drug.induced convulsion and staircase test. 
FolIowing oral administration of zopiclone to rabbits with chronicalIy implanted electrodes， 
electroencephalographic properties in spontaneous EEG such as slow waves with high ampli-
tudes in the neocortex were not evident. The arousal responses by the stimulation of the mid-
brain reticular formation， seizure discharges induced by stimulation of the dorsal hippocampus 
and the recruiting response induced by stimulation of the 位置usethalamic projecting system 
were not infl.uenced. 
In the tolerance.producing Iiability test where motor activities and pentetrazol-induced con-
vulsions were used as indices of tolerance for zopiclone， any sign of produced tolerance was not 
noticed even by continuous administration of zopiclone up to 30 days. 
The actions of several central acting drugs have been studied in the presence of zopiclone. 
Zopiclone did not a旺ecthypothermia induced by aspirin， analgesic action of pentazocine， vaso-
pressor action of ethylphenylephrine and behavioral actions of chlorpromazine， but potentiated 
anti-convulsive effects of phenytoin and imipramine. 
Based on the results obtained， the central nervous actions， tolerance-producing Iiability and 
interactions of zopiclone Were discussed. 
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経内投与群は 60分) 1<: pentetrazol 95 mgバg，




































ち O.5~百 CMC 投与の対照群 J zopiclone 6 mgバ沼，
diazepam 2 mg/kg (それぞれラットの pentetrazol
けいれんに対する抗けいれん作用の ED50の2倍量)




















































はそれぞれ1， 5 ， 10， 20， 50， 100 mg!kgを経口投
与した.










A : zopiclone 5 mgβ沼，
















zepamおよび nitrazepamでは TE消失の ED50












最け大い電れ撃ん b38emegAridg e pentetrazol bicuculline 95 mg!kg 2.5 mg/kg 
腹腔内 28 (24.1-32.5) 
diazepam 
32 (28.0-37.0) 1.2 (0.9-1.7) 0.46 (0.3-0.6) 1.3 (0.9-2.0) 経 ロ
腹腔内 180 (150-216) 
zopiclone 
5.2 (4，2-6.4) 6.6 (5.0-8.8) 5.7 (4.6-7.1) 経 口 >3∞ 
288 
ωunts加In.





a 5 6. 2 。』一一 1 ∞unts/mln. 
50 mg/kV 1lO 
C 







図 4. マウスの自発運動量11:及ぼす diazepamの
影響




















































4. Staircase test 
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図 6. 自発脳波IC及ぼすzopic1oneの影響
A:対照，





















2倍IC当る zopiclone6 mg!kg， diazepam 2 mg/kg 
を用いた.
2) 自発運動量










(mg!kg) 10 20 30 40日目
対 照 5 5 5 5 5 
















表 3. マウスの pentobarbital睡眠時間に及ぼす
zopicloneの影響
投与法 I，mg， 
対 照 1171 8.8土0.6 24.5土5.9
5 7.9土0.8 21.9:H.7 
経 口




10 11 4.4土0.4 69.0:18.4 
1群10匹以上の雄性7 ウスを用い， pentobarbi tal 表 4. "ウスの懸垂試験および回転棒試験K及lます
35mg!kg腹腔内投与の際の睡眠開始時間および持続 chlorpromazineとzopicIone併用の効果
時間を指標とし I zopicIone併用の効果を調べた.

































































TE消失の ED50の1/2差11:当る 15mg!kg， 7 mg/ 
kgをそれぞれ皮下投与し， zopiclone経口投与の最
大作用時(1.5-2時間後)1:電撃を行なった.結果は
表511:示すどとく， phenobarbi talとの併用では ED
















表 5. <'ウスの最大電撃けいれんに及ぼす抗てんかん薬および imipramineとzopiclone併用の効果
ED50 (955吉信頼限界)mg/kg 
薬 物 i ph(1e5nmobgaArbgi) tal 〈p7hmenEyバtoζgin) (i1z2n.i5prmagznkinge ) 
diazepam 10.5(8.0-13.日) 7.5(5.7-9.9) 
zopiclone 29α2.1-38.0) 70(48.3-101.5) 24(19.4-29.8) 
表 6. pentazocineの鎮痛作用1:対する zopic1one併用の効果
薬物と用量 Ha旺ner法 phenylquinone法
例数
(mg!kg) 関値士 S.E. stretching発現率
pentazocine 5 10 40(%) 
10 10 159.1土27.5 50 
diazepam 2 10 90 
5 10 86.5土7.0 100 
zopiclone 5 10 80 
10 10 91.8土5.4 100 
pentazocine 10 
+ 
diazepam 2 10 50 
5 10 83.6土5.0
pentazocine 10 




































昇圧剤として ethylphenylephrineを用い J ZOPIC-
loneとの併用効果を諮べた.なお血圧は総頚動脈IC挿
入したカニューレから水銀7 ノメー ター Ii:導く方法で
媒紙上lζ描記させた.α寸nethylDOP A 200 mgjkg 
腹腔内注射による長い血圧下降作用 (-15~20mm









として広く応用されIchlordiazepoxide， diazepam J 
nitrazepam， chlorazepate， clonazepamなどー速
の化合物が知られている.
"ー・・ 2 mg/l‘. 。
5 mghg p.o 
-ー._._.-A岬Irln・.0。飢Q/kl
-.._.._..- 2 m・IkQ+A.plrln.IOOm;lIt;
-ー-----ー 『ム=恒輔民三ー 、ーー 、--ザ九
‘ f 』 一ι4F，，e--・・........;-::::.・句切司山町吋. ζ;;;:~孟~
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